Item 2.02. Results of Operations and Financial Condition. On November 3, 2025, Biodesix, Inc. (the Company) issued a press release announcing the financial and operating results of the Company for the third quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference. The information contained in Item 2.02 to this Current Report on Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such document or filing.
BDSX Biodesix Inc - 8-K
Accession
0001193125-25-2625082.029.01
Item 2.02 - Results of Operations and Financial Condition
Earnings press release item. The actual results are typically in Exhibit 99.1 - fetch may not have completed.
Item 9.01 - Financial Statements and Exhibits
33 words
Item 9.01. Financial Statements and Exhibits. (d) Exhibits: No. Exhibit 99.1 Press Release issued by Biodesix, Inc. dated November 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)